Rabenaaf 20 mg (Capsule (Enteric Coated))
Unit Price: ৳ 8.00 (6 x 10: ৳ 480.00)
Strip Price: ৳ 80.00
Medicine Details
Category | Details |
---|---|
Generic | Rabeprazole sodium |
Company | Naafco pharma ltd |
Indications
- Active duodenal ulcers
- Active benign gastric ulcers
- GERD
- Zollinger-Ellison Syndrome
- H. pylori eradication
Pharmacology
Rabeprazole suppresses gastric acid secretion by inhibiting the gastric H+/K+-ATPase at the secretory surface of the gastric parietal cell.
Dosage
- 20mg once daily for active duodenal ulcer and active benign gastric ulcer
- 20mg once daily for 4-8 weeks for GERD
- 10mg or 20mg once daily for GERD maintenance
- 60mg to 120mg once daily for Zollinger-Ellison Syndrome
Administration
Should be taken in the morning before eating, should not be chewed or crushed, but swallowed whole.
Interaction
Potential interaction with ketoconazole, itraconazole, and atazanavir. No interaction with liquid antacids observed.
Contraindications
- Hypersensitivity to the active substance or excipients
- Contra-indicated in pregnancy and during breastfeeding.
Side Effects
- Headache
- Diarrhoea
- Abdominal pain
- Vomiting
- Constipation
- Dry mouth
- Muscle pain
- Drowsiness
- Dizziness
Pregnancy & Lactation
US FDA pregnancy category 'C'. No adequate and well-controlled studies in pregnant women. Rabeprazole is likely excreted in human milk.
Precautions & Warnings
- Malignancy should be excluded prior to commencing treatment
- Long-term treatment may increase risk of hip, wrist and spine fracture
- Hypomagnesaemia
- Interference with laboratory tests
- Influence on vitamin B12 absorption
- Subacute cutaneous lupus erythematosus (SCLE)
- Patients with hepatic impairment need caution
- Co-administration with atazanavir not recommended
- Possible increased risk of gastrointestinal infections
Use in Special Populations
- No dosage adjustment necessary for renal or hepatic impairment
- Not recommended for use in children
Overdose Effects
Effects generally minimal, reversible without further medical intervention. No specific antidote known. Not dialysable.
Therapeutic Class
Proton Pump Inhibitor
Storage Conditions
Keep below 30°C, away from light & moisture, keep out of the reach of children.
Chemical Structure
- Molecular Formula: C18H21N3O3S
- Chemical Structure Image: https://medex.com.bd/storage/res/g-res-942-rabeprazole-sodium-chemical-structure-atwg0Q4PlndQZhOY9GHX.svg
Common Questions
- What is Rabenaaf 20 mg Capsule?
- What is Rabenaaf 20 mg Capsule used for?
- What are the side effects of Rabenaaf 20 mg Capsule?
- How should I take Rabenaaf 20 mg Capsule?
- Can I take Rabenaaf 20 mg Capsule while pregnant or breastfeeding?
- What should I do if I overdose on Rabenaaf 20 mg Capsule?
- How long should I take Rabenaaf 20 mg Capsule?
- Is there anything else I should know about Rabenaaf 20 mg Capsule?
- Does Rabenaaf 20 mg Capsule cause bone problems?
- Can I take Rabenaaf 20 mg Capsule with vitamin D?
- Quick Tips
Related Brands
- Rabeprol 20 mg (Capsule (Enteric Coated)) - somatec-pharmaceuticals-ltd
- Rabepra 20 mg (Capsule (Enteric Coated)) - euro-pharma-ltd
- Rabipep 20 mg (Tablet (Enteric Coated)) - novatek-pharmaceuticals-ltd
- Finix 20 mg (Capsule (Enteric Coated)) - opsonin-pharma-ltd
- Rexiet 20 mg (Capsule (Enteric Coated)) - labaid-pharma-ltd